BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25157983)

  • 1. Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions.
    Wilson GK; Tennant DA; McKeating JA
    J Hepatol; 2014 Dec; 61(6):1397-406. PubMed ID: 25157983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia inducible factors regulate hepatitis B virus replication by activating the basal core promoter.
    Wing PAC; Liu PJ; Harris JM; Magri A; Michler T; Zhuang X; Borrmann H; Minisini R; Frampton NR; Wettengel JM; Mailly L; D'Arienzo V; Riedl T; Nobre L; Weekes MP; Pirisi M; Heikenwalder M; Baumert TF; Hammond EM; Mole DR; Protzer U; Balfe P; McKeating JA
    J Hepatol; 2021 Jul; 75(1):64-73. PubMed ID: 33516779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia and hypoxia inducible factors: diverse roles in liver diseases.
    Nath B; Szabo G
    Hepatology; 2012 Feb; 55(2):622-33. PubMed ID: 22120903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles of hypoxia-inducible factors and reactive oxygen species in cancer and pluripotent stem cells.
    Saito S; Lin YC; Tsai MH; Lin CS; Murayama Y; Sato R; Yokoyama KK
    Kaohsiung J Med Sci; 2015 Jun; 31(6):279-86. PubMed ID: 26043406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel links between HIFs, type 2 diabetes, and metabolic syndrome.
    Girgis CM; Cheng K; Scott CH; Gunton JE
    Trends Endocrinol Metab; 2012 Aug; 23(8):372-80. PubMed ID: 22766319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.
    Sun HX; Xu Y; Yang XR; Wang WM; Bai H; Shi RY; Nayar SK; Devbhandari RP; He YZ; Zhu QF; Sun YF; Hu B; Khan M; Anders RA; Fan J
    Hepatology; 2013 Mar; 57(3):1088-97. PubMed ID: 23212661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factors link iron homeostasis and erythropoiesis.
    Shah YM; Xie L
    Gastroenterology; 2014 Mar; 146(3):630-42. PubMed ID: 24389303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factors as molecular targets for liver diseases.
    Ju C; Colgan SP; Eltzschig HK
    J Mol Med (Berl); 2016 Jun; 94(6):613-27. PubMed ID: 27094811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factors and obstructive sleep apnea.
    Prabhakar NR; Peng YJ; Nanduri J
    J Clin Invest; 2020 Oct; 130(10):5042-5051. PubMed ID: 32730232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-Induced Signaling in Gut and Liver Pathobiology.
    Solanki S; Shah YM
    Annu Rev Pathol; 2024 Jan; 19():291-317. PubMed ID: 37832943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia.
    Shohet RV; Garcia JA
    J Mol Med (Berl); 2007 Dec; 85(12):1309-15. PubMed ID: 18026917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crosstalk between HIFs and mitochondrial dysfunctions in cancer development.
    Bao X; Zhang J; Huang G; Yan J; Xu C; Dou Z; Sun C; Zhang H
    Cell Death Dis; 2021 Feb; 12(2):215. PubMed ID: 33637686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factors and cancer.
    Calzada MJ; del Peso L
    Clin Transl Oncol; 2007 May; 9(5):278-89. PubMed ID: 17525038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypoxia-adenosine link during inflammation.
    Bowser JL; Lee JW; Yuan X; Eltzschig HK
    J Appl Physiol (1985); 2017 Nov; 123(5):1303-1320. PubMed ID: 28798196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between MYC and HIF in cancer.
    Dang CV; Kim JW; Gao P; Yustein J
    Nat Rev Cancer; 2008 Jan; 8(1):51-6. PubMed ID: 18046334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy.
    Yu T; Tang B; Sun X
    Yonsei Med J; 2017 May; 58(3):489-496. PubMed ID: 28332352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.
    Wigerup C; PĂ„hlman S; Bexell D
    Pharmacol Ther; 2016 Aug; 164():152-69. PubMed ID: 27139518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.
    Farquhar MJ; Humphreys IS; Rudge SA; Wilson GK; Bhattacharya B; Ciaccia M; Hu K; Zhang Q; Mailly L; Reynolds GM; Ashcroft M; Balfe P; Baumert TF; Roessler S; Wakelam MJO; McKeating JA
    J Hepatol; 2017 May; 66(5):919-929. PubMed ID: 28126468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics.
    Nguyen MP; Lee S; Lee YM
    Arch Pharm Res; 2013 Mar; 36(3):252-63. PubMed ID: 23440580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-connection between mitochondria and HIFs.
    Tormos KV; Chandel NS
    J Cell Mol Med; 2010 Apr; 14(4):795-804. PubMed ID: 20158574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.